In pulmonary hypertension, Gal-3 activates the AKT signaling pathway to overactivate pulmonary vascular adventitial fibroblasts, promoting the occurrence and development of PAH (pulmonary arterial hypertension) (Barman et al., 2019). This evidence concerns the gene AKT1 and pulmonary arterial hypertension.